Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-Dl): a novel instrument to quantify organ damage in systemic sclerosis (vol 78, pg 807, 2019)

被引：2
|
作者：
Ferdowsi, N.
Huq, M.
Stevens, W.
机构：
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷 / 08期
关键词：
D O I：
10.1136/annrheumdis-2018-214764corr1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 7 条
  • [1] Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis
    Ferdowsi, Nava
    Huq, Molla
    Stevens, Wendy
    Hudson, Marie
    Wang, Mianbo
    Tay, Tien
    Burchell, Jodie L.
    Mancuso, Sam
    Rabusa, Candice
    Sundararajan, Vijaya
    Prior, David
    Proudman, Susanna M.
    Baron, Murray
    Nikpour, Mandana
    Frech, Tracy
    Hudson, Marie
    Proudman, Susanna
    Stevens, Wendy
    Tay, Tien
    Chatterjee, Souyma
    Chung, Lorinda
    Gordon, Jessica K.
    Haemel, Anna
    Johnson, Sindhu R.
    Khanna, Dinesh
    Medsger, Thomas A.
    Merkel, Peter
    Pauling, John
    Pope, Janet E.
    Rodriguez-Reyna, Tatiana
    Saketkoo, Lesley
    Seibold, James R.
    Shah, Ankoor
    Steen, Virginia
    Strickland, Gemma
    Ngian, Gene-Siew
    Nikpour, Mandana
    Proudman, Susanna
    Rischmueller, Maureen
    Roddy, Janet
    Sahhar, Joanne
    Stevens, Wendy
    Strickland, Gemma
    Walker, Jenny
    Youssef, Peter
    Pope, J.
    Baron, M.
    Markland, J.
    Robinson, D.
    Jones, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (06) : 807 - 816
  • [2] TO ASSESS THE SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) IN PATIENTS WITH SYSTEMIC SCLEROSIS IN RUSSIAN COHORT PATIENTS.
    Ovsyannikova, O.
    Koneva, O.
    Garzanova, L.
    Ananyeva, L. P.
    Shayakhmetova, R.
    Desinova, O.
    Khelkovskaia-Sergeeva, A.
    Starovoytova, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1489 - 1489
  • [3] THE IMPACT OF OVERLAP SYNDROMES ON THE SCLERODERMA CLINICAL TRIAL CONSORTIUM DAMAGE INDEX (SCTC-DI) IN SYSTEMIC SCLEROSIS
    Filipanits, K.
    Nagy, G.
    Komjati, D.
    Kumanovics, G.
    Varju, C.
    Czirjak, L.
    Minier, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 979 - 979
  • [4] THE SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) IN A SYSTEMIC SCLEROSIS COHORT WITH 10-YEARS FOLLOW-UP
    Lazzaroni, M. G.
    Breda, M.
    Franceschini, F.
    Airo., P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 166 - 166
  • [5] THE SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) IN PATIENTS WITH SYSTEMIC SCLEROSIS/INTERSTITIAL LUNG DISEASE AS A NEW SEVERITY ASSESSMENT TOOL
    Ovsynnikova, Olga
    Koneva, Olga
    Desinova, Oxana
    Ananyeva, Lidia
    Garzanova, Liudmila
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    [J]. CHEST, 2022, 162 (04) : 2198A - 2198A
  • [6] CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF PATIENTS WITH SYSTEMIC SCLEROSIS IN DIFFERENT INTERVAL SEPARATED BY SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) IN RUSSIAN COHORT PATIENTS.
    Ovsyannikova, O.
    Koneva, O.
    Garzanova, L.
    Khelkovskaia-Sergeeva, A.
    Desinova, O.
    Starovoytova, M.
    Shayakhmetova, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1491 - 1492
  • [7] SMOKING HISTORY AND SCLERODERMA CLINICAL TRIALS CONSORTIUM DAMAGE INDEX (SCTC-DI) AS INDEPENDENT PREDICTORS OF MORTALITY IN SYSTEMIC SCLEROSIS IN A SINGLE-CENTRE ITALIAN COHORT
    Breda, M.
    Lazzaroni, M. G.
    Franceschini, F.
    Airo, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 389 - 389
1